Published in Nat Rev Neurol on November 20, 2012
The retina as an early biomarker of neurodegeneration in a rotenone-induced model of Parkinson's disease: evidence for a neuroprotective effect of rosiglitazone in the eye and brain. Acta Neuropathol Commun (2016) 1.46
A new glaucoma hypothesis: a role of glymphatic system dysfunction. Fluids Barriers CNS (2015) 1.27
Noninvasive two-photon microscopy imaging of mouse retina and retinal pigment epithelium through the pupil of the eye. Nat Med (2014) 1.14
Systems pharmacology identifies drug targets for Stargardt disease-associated retinal degeneration. J Clin Invest (2013) 1.06
Successful arrest of photoreceptor and vision loss expands the therapeutic window of retinal gene therapy to later stages of disease. Proc Natl Acad Sci U S A (2015) 0.97
Contribution of microglia-mediated neuroinflammation to retinal degenerative diseases. Mediators Inflamm (2015) 0.96
Ocular changes in TgF344-AD rat model of Alzheimer's disease. Invest Ophthalmol Vis Sci (2014) 0.91
Massively parallel cis-regulatory analysis in the mammalian central nervous system. Genome Res (2015) 0.89
Thioredoxin Interacting Protein (TXNIP) and Pathogenesis of Diabetic Retinopathy. J Clin Exp Ophthalmol (2013) 0.86
Retinal imaging as a source of biomarkers for diagnosis, characterization and prognosis of chronic illness or long-term conditions. Br J Radiol (2014) 0.86
A systematic review and meta-analysis of retinal nerve fiber layer change in dementia, using optical coherence tomography. Alzheimers Dement (Amst) (2015) 0.84
Retinal involvement in amyotrophic lateral sclerosis: a study with optical coherence tomography and diffusion tensor imaging. J Neural Transm (Vienna) (2015) 0.83
Suitability of UK Biobank Retinal Images for Automatic Analysis of Morphometric Properties of the Vasculature. PLoS One (2015) 0.82
Polarization properties of single layers in the posterior eyes of mice and rats investigated using high resolution polarization sensitive optical coherence tomography. Biomed Opt Express (2016) 0.80
Ocular indicators of Alzheimer's: exploring disease in the retina. Acta Neuropathol (2016) 0.80
Visual and Ocular Manifestations of Alzheimer's Disease and Their Use as Biomarkers for Diagnosis and Progression. Front Neurol (2016) 0.80
Midkine-a protein localization in the developing and adult retina of the zebrafish and its function during photoreceptor regeneration. PLoS One (2015) 0.80
The Endocannabinoid System in the Retina: From Physiology to Practical and Therapeutic Applications. Neural Plast (2016) 0.78
Bone Marrow-Derived Cells as a Therapeutic Approach to Optic Nerve Diseases. Stem Cells Int (2015) 0.78
In vitro models of axon regeneration. Exp Neurol (2016) 0.78
Eyeing the brain. Acta Neuropathol (2016) 0.78
[Retinal imaging of the macula and optic disc in neurodegenerative diseases]. Ophthalmologe (2017) 0.77
Early retinal inflammatory biomarkers in the middle cerebral artery occlusion model of ischemic stroke. Mol Vis (2016) 0.77
Early retinal function deficit without prominent morphological changes in the R6/2 mouse model of Huntington's disease. PLoS One (2014) 0.77
Long Noncoding RNA-Sox2OT Knockdown Alleviates Diabetes Mellitus-Induced Retinal Ganglion Cell (RGC) injury. Cell Mol Neurobiol (2016) 0.77
Retinal Degeneration In A Mouse Model Of CLN5 Disease Is Associated With Compromised Autophagy. Sci Rep (2017) 0.76
Long non-coding RNA MALAT1 regulates retinal neurodegeneration through CREB signaling. EMBO Mol Med (2016) 0.76
Developing retinal biomarkers of neurological disease: an analytical perspective. Biomark Med (2015) 0.76
Beta-amyloid sequelae in the eye: a critical review on its diagnostic significance and clinical relevance in Alzheimer's disease. Mol Psychiatry (2017) 0.76
Immune response in the eye following epileptic seizures. J Neuroinflammation (2016) 0.76
Long non-coding RNA-MIAT promotes neurovascular remodeling in the eye and brain. Oncotarget (2016) 0.76
Grading fluorescein angiograms in malarial retinopathy. Malar J (2015) 0.76
Commentary: Anatomical constitution of sense organs as a marker of mental disorders. Front Behav Neurosci (2016) 0.75
Size-selective opening of the blood-brain barrier by targeting endothelial sphingosine 1-phosphate receptor 1. Proc Natl Acad Sci U S A (2017) 0.75
The application of retinal fundus camera imaging in dementia: A systematic review. Alzheimers Dement (Amst) (2016) 0.75
Investigations into Retinal Pathology in the Early Stages of a Mouse Model of Alzheimer's Disease. J Alzheimers Dis (2016) 0.75
Visualization of neuritic plaques in Alzheimer's disease by polarization-sensitive optical coherence microscopy. Sci Rep (2017) 0.75
Comparative Proteomic Analysis of the Mitochondria-associated ER Membrane (MAM) in a Long-term Type 2 Diabetic Rodent Model. Sci Rep (2017) 0.75
From Imaging the Brain to Imaging the Retina: Optical Coherence Tomography (OCT) in Schizophrenia. Schizophr Bull (2015) 0.75
Probing electrical signals in the retina via graphene-integrated microfluidic platforms. Nanoscale (2016) 0.75
Peripapillary Retinal Nerve Fiber Layer Thickness and the Evolution of Cognitive Performance in an Elderly Population. Front Neurol (2017) 0.75
Knockdown of zebrafish blood vessel epicardial substance results in incomplete retinal lamination. ScientificWorldJournal (2014) 0.75
Brain-derived neurotrophic factor in patients with advanced age-related macular degeneration. Int J Ophthalmol (2015) 0.75
Turning Down the Thermostat: Modulating the Endocannabinoid System in Ocular Inflammation and Pain. Front Pharmacol (2016) 0.75
Retina Is Protected by Neuroserpin from Ischemic/Reperfusion-Induced Injury Independent of Tissue-Type Plasminogen Activator. PLoS One (2015) 0.75
The correlation between cognitive performance and retinal nerve fibre layer thickness is largely explained by genetic factors. Sci Rep (2016) 0.75
Cellular Stress Response and Immune Signaling in Retinal Ischemia-Reperfusion Injury. Front Immunol (2016) 0.75
Effects of copper oxide nanoparticles on developing zebrafish embryos and larvae. Int J Nanomedicine (2016) 0.75
Retinal microvascular network alterations: potential biomarkers of cerebrovascular and neural diseases. Am J Physiol Heart Circ Physiol (2016) 0.75
Ophthalmologic Psychophysical Tests Support OCT Findings in Mild Alzheimer's Disease. J Ophthalmol (2015) 0.75
The Retina in Multiple System Atrophy: Systematic Review and Meta-Analysis. Front Neurol (2017) 0.75
Age-related neurodegenerative disease associated pathways identified in retinal and vitreous proteome from human glaucoma eyes. Sci Rep (2017) 0.75
Roles of microRNAs and Long Noncoding RNAs in the Progression of Diabetic Retinopathy. Biosci Rep (2017) 0.75
Non-invasive intracranial pressure assessment. Childs Nerv Syst (2016) 0.75
The Glymphatic Hypothesis of Glaucoma: A Unifying Concept Incorporating Vascular, Biomechanical, and Biochemical Aspects of the Disease. Biomed Res Int (2017) 0.75
The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science (2002) 49.51
Alzheimer's disease is a synaptic failure. Science (2002) 13.82
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet (2004) 13.18
Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature (1999) 12.95
Regeneration beyond the glial scar. Nat Rev Neurosci (2004) 11.00
Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis. Ophthalmology (2006) 4.72
Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis. Neurology (2007) 4.72
Myelin-associated inhibitors of axonal regeneration in the adult mammalian CNS. Nat Rev Neurosci (2003) 4.60
Axonal elongation into peripheral nervous system "bridges" after central nervous system injury in adult rats. Science (1981) 3.94
Ocular immune privilege: therapeutic opportunities from an experiment of nature. Nat Rev Immunol (2003) 3.74
Is breakdown of the blood-brain barrier responsible for lacunar stroke, leukoaraiosis, and dementia? Stroke (2003) 3.58
Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys. Nat Med (1997) 3.55
Retinal microvascular abnormalities and incident stroke: the Atherosclerosis Risk in Communities Study. Lancet (2001) 3.28
Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy. Nat Med (1999) 3.13
Retinal vascular image analysis as a potential screening tool for cerebrovascular disease: a rationale based on homology between cerebral and retinal microvasculatures. J Anat (2005) 3.02
Optical coherence tomography in multiple sclerosis: a systematic review and meta-analysis. Lancet Neurol (2010) 2.99
Retinal ganglion cell degeneration is topological but not cell type specific in DBA/2J mice. J Cell Biol (2005) 2.98
Progressive ganglion cell degeneration precedes neuronal loss in a mouse model of glaucoma. J Neurosci (2008) 2.87
The Alzheimer's A beta -peptide is deposited at sites of complement activation in pathologic deposits associated with aging and age-related macular degeneration. Proc Natl Acad Sci U S A (2002) 2.74
Cerebral white matter lesions, retinopathy, and incident clinical stroke. JAMA (2002) 2.72
Ocular pathology in multiple sclerosis: retinal atrophy and inflammation irrespective of disease duration. Brain (2010) 2.61
Retinal microvascular abnormalities and their relationship with hypertension, cardiovascular disease, and mortality. Surv Ophthalmol (2001) 2.51
Nogo and axon regeneration. Curr Opin Neurobiol (2004) 2.48
Optic-nerve degeneration in Alzheimer's disease. N Engl J Med (1986) 2.20
An investigation of the retinal nerve fibre layer in progressive multiple sclerosis using optical coherence tomography. Brain (2007) 2.18
Inactivation of Rho signaling pathway promotes CNS axon regeneration. J Neurosci (1999) 2.13
Invited Article: Nervous system pathology in sporadic Parkinson disease. Neurology (2008) 2.13
Optic nerve damage in Alzheimer's disease. Ophthalmology (1990) 2.06
Lacunar stroke is associated with diffuse blood-brain barrier dysfunction. Ann Neurol (2009) 1.98
Blood-retinal barrier in hypoxic ischaemic conditions: basic concepts, clinical features and management. Prog Retin Eye Res (2008) 1.93
Cytosolic beta-amyloid deposition and supranuclear cataracts in lenses from people with Alzheimer's disease. Lancet (2003) 1.91
Reduction of optic nerve fibers in patients with Alzheimer disease identified by laser imaging. Neurology (2006) 1.83
Abnormal retinal thickness in patients with mild cognitive impairment and Alzheimer's disease. Neurosci Lett (2007) 1.80
Glaucoma as a neurodegenerative disease. Curr Opin Ophthalmol (2007) 1.80
Neuroprotection and progenitor cell renewal in the injured adult murine retina requires healing monocyte-derived macrophages. J Exp Med (2011) 1.80
Optical coherence tomography helps differentiate neuromyelitis optica and MS optic neuropathies. Neurology (2009) 1.78
Targeting amyloid-beta in glaucoma treatment. Proc Natl Acad Sci U S A (2007) 1.77
Retinal microvascular abnormalities and subclinical magnetic resonance imaging brain infarct: a prospective study. Brain (2010) 1.73
Mutations in FLVCR1 cause posterior column ataxia and retinitis pigmentosa. Am J Hum Genet (2010) 1.72
Retinal pathologic changes in multiple sclerosis. Retina (1994) 1.71
Optic neuritis and multiple sclerosis. Acta Ophthalmol Scand (2001) 1.70
Amyloid-beta deposits lead to retinal degeneration in a mouse model of Alzheimer disease. Invest Ophthalmol Vis Sci (2008) 1.70
Retinal nerve fiber layer thinning in Parkinson disease. Vision Res (2004) 1.67
Amyloid-beta is found in drusen from some age-related macular degeneration retinas, but not in drusen from normal retinas. Mol Vis (2003) 1.66
Retinal abnormalities in early Alzheimer's disease. Invest Ophthalmol Vis Sci (2007) 1.65
Protective autoimmunity is a physiological response to CNS trauma. J Neurosci (2001) 1.64
Relationship between cognitive impairment and retinal morphological and visual functional abnormalities in Alzheimer disease. J Neuroophthalmol (2006) 1.63
T cell immunity to copolymer 1 confers neuroprotection on the damaged optic nerve: possible therapy for optic neuropathies. Proc Natl Acad Sci U S A (2000) 1.61
Vaccination for protection of retinal ganglion cells against death from glutamate cytotoxicity and ocular hypertension: implications for glaucoma. Proc Natl Acad Sci U S A (2001) 1.61
Inhibition of Rho kinase (ROCK) increases neurite outgrowth on chondroitin sulphate proteoglycan in vitro and axonal regeneration in the adult optic nerve in vivo. J Neurochem (2007) 1.59
Morphological and functional retinal impairment in Alzheimer's disease patients. Clin Neurophysiol (2001) 1.59
Identification of amyloid plaques in retinas from Alzheimer's patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model. Neuroimage (2010) 1.59
Inner retinal layer thinning in Parkinson disease. Arch Ophthalmol (2009) 1.58
Iron misregulation in the brain: a primary cause of neurodegenerative disorders. Lancet Neurol (2003) 1.57
The potential role of amyloid beta in the pathogenesis of age-related macular degeneration. J Clin Invest (2005) 1.56
Anti-amyloid therapy protects against retinal pigmented epithelium damage and vision loss in a model of age-related macular degeneration. Proc Natl Acad Sci U S A (2011) 1.56
Retinal signs and stroke: revisiting the link between the eye and brain. Stroke (2008) 1.54
Axonal regeneration and synapse formation in the superior colliculus by retinal ganglion cells in the adult rat. J Neurosci (1987) 1.53
Axonal degeneration in motor neuron disease. Neurodegener Dis (2007) 1.53
Optical coherence tomography differs in neuromyelitis optica compared with multiple sclerosis. Neurology (2009) 1.52
Counteracting the Nogo receptor enhances optic nerve regeneration if retinal ganglion cells are in an active growth state. J Neurosci (2004) 1.51
Oncomodulin links inflammation to optic nerve regeneration. Proc Natl Acad Sci U S A (2009) 1.50
Retinal microvascular changes and subsequent vascular events after ischemic stroke. Neurology (2011) 1.49
Influences of peripheral nerve grafts on the survival and regrowth of axotomized retinal ganglion cells in adult rats. J Neurosci (1988) 1.47
A model to study differences between primary and secondary degeneration of retinal ganglion cells in rats by partial optic nerve transection. Invest Ophthalmol Vis Sci (2003) 1.46
Correlation between retinal morphological and functional findings and clinical severity in Parkinson's disease. Doc Ophthalmol (2007) 1.46
Retinal pathology in Alzheimer's disease. I. Ganglion cell loss in foveal/parafoveal retina. Neurobiol Aging (1996) 1.46
Nasal vaccination with a proteosome-based adjuvant and glatiramer acetate clears beta-amyloid in a mouse model of Alzheimer disease. J Clin Invest (2005) 1.45
Optical coherence tomography is less sensitive than visual evoked potentials in optic neuritis. Neurology (2009) 1.44
Drusen deposits associated with aging and age-related macular degeneration contain nonfibrillar amyloid oligomers. J Clin Invest (2006) 1.43
Retinal thickness in patients with mild cognitive impairment and Alzheimer's disease. Clin Neurol Neurosurg (2011) 1.42
Nasal vaccination with myelin oligodendrocyte glycoprotein reduces stroke size by inducing IL-10-producing CD4+ T cells. J Immunol (2003) 1.40
Is retinal photography useful in the measurement of stroke risk? Lancet Neurol (2004) 1.39
Retinal nerve fiber layer thickness is associated with brain MRI outcomes in multiple sclerosis. J Neurol Sci (2007) 1.39
The retina in Parkinson's disease. Brain (2009) 1.34
Amyloid-peptide vaccinations reduce {beta}-amyloid plaques but exacerbate vascular deposition and inflammation in the retina of Alzheimer's transgenic mice. Am J Pathol (2009) 1.33
Fluids from immune privileged sites endow macrophages with the capacity to induce antigen-specific immune deviation via a mechanism involving transforming growth factor-beta. Eur J Immunol (1992) 1.29
Two faces of chondroitin sulfate proteoglycan in spinal cord repair: a role in microglia/macrophage activation. PLoS Med (2008) 1.28
Retinal pathology in Alzheimer's disease. II. Regional neuron loss and glial changes in GCL. Neurobiol Aging (1996) 1.28
Long-term follow-up of isolated optic neuritis: the risk of developing multiple sclerosis, its outcome, and the prognostic role of paraclinical tests. J Neurol (1999) 1.27
Vitreous fluid levels of beta-amyloid((1-42)) and tau in patients with retinal diseases. Jpn J Ophthalmol (2005) 1.26
The ocular manifestations of multiple sclerosis. 1. Abnormalities of the afferent visual system. J Neurol Neurosurg Psychiatry (1992) 1.26
Alzheimer's disease and retinal neurodegeneration. Curr Alzheimer Res (2010) 1.26
EGF and TGF-alpha stimulate retinal neuroepithelial cell proliferation in vitro. Neuron (1991) 1.24
Optic nerve transection in monkeys may result in secondary degeneration of retinal ganglion cells. Invest Ophthalmol Vis Sci (2001) 1.24
Quantification of retinal neural loss in patients with neuromyelitis optica and multiple sclerosis with or without optic neuritis using Fourier-domain optical coherence tomography. Invest Ophthalmol Vis Sci (2012) 1.24
Retinal ganglion cell degeneration in Alzheimer's disease. Brain Res (1989) 1.20
Degeneration of spared axons following partial white matter lesion: implications for optic nerve neuropathies. Exp Neurol (1998) 1.20
Morphologic changes and functional retinal impairment in patients with Parkinson disease without visual loss. Eur J Ophthalmol (2011) 1.19
Targeting age-related macular degeneration with Alzheimer's disease based immunotherapies: anti-amyloid-beta antibody attenuates pathologies in an age-related macular degeneration mouse model. Vision Res (2007) 1.18
Soluble and mature amyloid fibrils in drusen deposits. Invest Ophthalmol Vis Sci (2009) 1.18
Glaucoma of the brain: a disease model for the study of transsynaptic neural degeneration. Prog Brain Res (2008) 1.15
Therapies for Alzheimer's disease. Nat Rev Drug Discov (2007) 1.13
Early high-dose intravenous methylprednisolone is effective in preserving retinal nerve fiber layer thickness in patients with neuromyelitis optica. Graefes Arch Clin Exp Ophthalmol (2010) 1.11
Rewiring the injured CNS: lessons from the optic nerve. Exp Neurol (2007) 1.11
Toll-like receptor 4 restricts retinal progenitor cell proliferation. J Cell Biol (2008) 1.09
Memantine protects neurons from shrinkage in the lateral geniculate nucleus in experimental glaucoma. Arch Ophthalmol (2006) 1.08
Increased expression of iron-regulating genes in monkey and human glaucoma. Invest Ophthalmol Vis Sci (2004) 1.07
Neurodegeneration and cellular stress in the retina and optic nerve in rat cerebral ischemia and hypoperfusion models. Neuroscience (2008) 1.04
Immune cells contribute to the maintenance of neurogenesis and spatial learning abilities in adulthood. Nat Neurosci (2006) 4.30
Toll-like receptors modulate adult hippocampal neurogenesis. Nat Cell Biol (2007) 4.00
Microglia activated by IL-4 or IFN-gamma differentially induce neurogenesis and oligodendrogenesis from adult stem/progenitor cells. Mol Cell Neurosci (2005) 3.77
Infiltrating blood-derived macrophages are vital cells playing an anti-inflammatory role in recovery from spinal cord injury in mice. PLoS Med (2009) 3.68
The bright side of the glial scar in CNS repair. Nat Rev Neurosci (2009) 2.34
Recruitment of beneficial M2 macrophages to injured spinal cord is orchestrated by remote brain choroid plexus. Immunity (2013) 2.08
Glatiramer acetate fights against Alzheimer's disease by inducing dendritic-like microglia expressing insulin-like growth factor 1. Proc Natl Acad Sci U S A (2006) 1.92
T cell deficiency leads to cognitive dysfunction: implications for therapeutic vaccination for schizophrenia and other psychiatric conditions. Proc Natl Acad Sci U S A (2004) 1.91
Spinal cord injury: time to move? J Neurosci (2007) 1.87
Neuroprotection and progenitor cell renewal in the injured adult murine retina requires healing monocyte-derived macrophages. J Exp Med (2011) 1.80
Induction and blockage of oligodendrogenesis by differently activated microglia in an animal model of multiple sclerosis. J Clin Invest (2006) 1.78
Clinical experience using incubated autologous macrophages as a treatment for complete spinal cord injury: phase I study results. J Neurosurg Spine (2005) 1.77
Schizophrenia: from the brain to peripheral markers. A consensus paper of the WFSBP task force on biological markers. World J Biol Psychiatry (2009) 1.64
Identification of amyloid plaques in retinas from Alzheimer's patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model. Neuroimage (2010) 1.59
Activation of microglia by aggregated beta-amyloid or lipopolysaccharide impairs MHC-II expression and renders them cytotoxic whereas IFN-gamma and IL-4 render them protective. Mol Cell Neurosci (2005) 1.59
Neuroprotective autoimmunity: naturally occurring CD4+CD25+ regulatory T cells suppress the ability to withstand injury to the central nervous system. Proc Natl Acad Sci U S A (2002) 1.58
Cross-talk between neural stem cells and immune cells: the key to better brain repair? Nat Neurosci (2012) 1.55
Synergy between immune cells and adult neural stem/progenitor cells promotes functional recovery from spinal cord injury. Proc Natl Acad Sci U S A (2006) 1.50
Brain regeneration in physiology and pathology: the immune signature driving therapeutic plasticity of neural stem cells. Physiol Rev (2011) 1.40
Orchestrated leukocyte recruitment to immune-privileged sites: absolute barriers versus educational gates. Nat Rev Immunol (2013) 1.39
Harnessing monocyte-derived macrophages to control central nervous system pathologies: no longer 'if' but 'how'. J Pathol (2012) 1.36
Microglia and monocyte-derived macrophages: functionally distinct populations that act in concert in CNS plasticity and repair. Front Cell Neurosci (2013) 1.34
Two faces of chondroitin sulfate proteoglycan in spinal cord repair: a role in microglia/macrophage activation. PLoS Med (2008) 1.28
Early activation of microglia as antigen-presenting cells correlates with T cell-mediated protection and repair of the injured central nervous system. J Neuroimmunol (2004) 1.28
IFN-γ-dependent activation of the brain's choroid plexus for CNS immune surveillance and repair. Brain (2013) 1.26
Selective ablation of bone marrow-derived dendritic cells increases amyloid plaques in a mouse Alzheimer's disease model. Eur J Neurosci (2007) 1.24
Dual effect of CD4+CD25+ regulatory T cells in neurodegeneration: a dialogue with microglia. Proc Natl Acad Sci U S A (2004) 1.22
Maladaptation to mental stress mitigated by the adaptive immune system via depletion of naturally occurring regulatory CD4+CD25+ cells. J Neurobiol (2006) 1.21
Dopamine, through the extracellular signal-regulated kinase pathway, downregulates CD4+CD25+ regulatory T-cell activity: implications for neurodegeneration. J Neurosci (2004) 1.20
CNS-specific immunity at the choroid plexus shifts toward destructive Th2 inflammation in brain aging. Proc Natl Acad Sci U S A (2013) 1.16
The glial scar-monocyte interplay: a pivotal resolution phase in spinal cord repair. PLoS One (2011) 1.11
CNS-specific T cells shape brain function via the choroid plexus. Brain Behav Immun (2013) 1.11
Toll-like receptor 4 restricts retinal progenitor cell proliferation. J Cell Biol (2008) 1.09
Reducing post-traumatic anxiety by immunization. Brain Behav Immun (2008) 1.07
New GABAergic interneurons supported by myelin-specific T cells are formed in intact adult spinal cord. Stem Cells (2007) 1.06
Immune-based regulation of adult neurogenesis: implications for learning and memory. Brain Behav Immun (2007) 1.05
Microglia can be induced by IFN-gamma or IL-4 to express neural or dendritic-like markers. Mol Cell Neurosci (2007) 1.04
Vaccination as a novel approach for treating depressive behavior. Biol Psychiatry (2008) 1.03
Vaccination with autoantigen protects against aggregated beta-amyloid and glutamate toxicity by controlling microglia: effect of CD4+CD25+ T cells. Eur J Immunol (2004) 1.02
Attenuation of AD-like neuropathology by harnessing peripheral immune cells: local elevation of IL-10 and MMP-9. J Neurochem (2009) 1.02
T-cell-based vaccination for morphological and functional neuroprotection in a rat model of chronically elevated intraocular pressure. J Mol Med (Berl) (2005) 1.01
Abnormal changes in NKT cells, the IGF-1 axis, and liver pathology in an animal model of ALS. PLoS One (2011) 1.00
Resistance of retinal ganglion cells to an increase in intraocular pressure is immune-dependent. Invest Ophthalmol Vis Sci (2002) 0.99
Non-identical twins - microglia and monocyte-derived macrophages in acute injury and autoimmune inflammation. Front Immunol (2012) 0.99
Neuroprotective effect of memantine in different retinal injury models in rats. J Glaucoma (2002) 0.98
Myelin specific Th1 cells are necessary for post-traumatic protective autoimmunity. J Neuroimmunol (2002) 0.98
Immunotherapy for neurological diseases. Clin Immunol (2008) 0.97
Controlled autoimmunity in CNS maintenance and repair: naturally occurring CD4+CD25+ regulatory T-Cells at the crossroads of health and disease. Neuromolecular Med (2005) 0.97
Low-dose gamma-irradiation promotes survival of injured neurons in the central nervous system via homeostasis-driven proliferation of T cells. Eur J Neurosci (2004) 0.97
Excess circulating alternatively activated myeloid (M2) cells accelerate ALS progression while inhibiting experimental autoimmune encephalomyelitis. PLoS One (2011) 0.96
A novel immune-based therapy for stroke induces neuroprotection and supports neurogenesis. Stroke (2007) 0.96
The privileged immunity of immune privileged organs: the case of the eye. Front Immunol (2012) 0.95
Therapeutic vaccination for closed head injury. J Neurotrauma (2003) 0.95
Sexual dimorphism in the spontaneous recovery from spinal cord injury: a gender gap in beneficial autoimmunity? Eur J Neurosci (2002) 0.93
CNS sterile injury: just another wound healing? Trends Mol Med (2012) 0.93
Orchestrating brain-cell renewal: the role of immune cells in adult neurogenesis in health and disease. Trends Mol Med (2008) 0.92
Thymic involution, a co-morbidity factor in amyotrophic lateral sclerosis. J Cell Mol Med (2010) 0.91
A sulfated disaccharide derived from chondroitin sulfate proteoglycan protects against inflammation-associated neurodegeneration. FASEB J (2006) 0.91
Autoreactive T cells induce neurotrophin production by immune and neural cells in injured rat optic nerve: implications for protective autoimmunity. FASEB J (2002) 0.91
Glial scar and immune cell involvement in tissue remodeling and repair following acute CNS injuries. Glia (2014) 0.91
Vaccination with dendritic cells pulsed with peptides of myelin basic protein promotes functional recovery from spinal cord injury. J Neurosci (2003) 0.91
Dual action of glatiramer acetate (Cop-1) in the treatment of CNS autoimmune and neurodegenerative disorders. Trends Mol Med (2002) 0.91
Therapeutic vaccination for spinal cord injury: helping the body to cure itself. Trends Pharmacol Sci (2003) 0.90
Autoimmunity as an immune defense against degenerative processes: a primary mathematical model illustrating the bright side of autoimmunity. J Theor Biol (2004) 0.89
Autoimmunity as a special case of immunity: removing threats from within. Trends Mol Med (2003) 0.89
Antigenic specificity of immunoprotective therapeutic vaccination for glaucoma. Invest Ophthalmol Vis Sci (2003) 0.89
A disaccharide derived from chondroitin sulphate proteoglycan promotes central nervous system repair in rats and mice. Eur J Neurosci (2004) 0.88
Immune senescence and brain aging: can rejuvenation of immunity reverse memory loss? Trends Neurosci (2009) 0.86
The therapeutic window after spinal cord injury can accommodate T cell-based vaccination and methylprednisolone in rats. Eur J Neurosci (2004) 0.86
Functional macrophage heterogeneity in a mouse model of autoimmune central nervous system pathology. J Immunol (2013) 0.86
Brain homeostasis is maintained by "danger" signals stimulating a supportive immune response within the brain's borders. Brain Behav Immun (2010) 0.85
Weekly vaccination with Copaxone (glatiramer acetate) as a potential therapy for dry age-related macular degeneration. Curr Eye Res (2008) 0.84
Hypothalamic neuronal toll-like receptor 2 protects against age-induced obesity. Sci Rep (2013) 0.84
Genetic manipulation of CD74 in mouse strains of different backgrounds can result in opposite responses to central nervous system injury. J Immunol (2007) 0.84
Severe immunodeficiency has opposite effects on neuronal survival in glutamate-susceptible and -resistant mice: adverse effect of B cells. J Immunol (2002) 0.84
Beneficial autoimmunity in Type 1 diabetes mellitus. Trends Immunol (2005) 0.84
The tissue-specific self-pathogen is the protective self-antigen: the case of uveitis. J Immunol (2002) 0.83
CD4(+) T Cell-Receptor Repertoire Diversity is Compromised in the Spleen but Not in the Bone Marrow of Aged Mice Due to Private and Sporadic Clonal Expansions. Front Immunol (2013) 0.83
Immune-related mechanisms participating in resistance and susceptibility to glutamate toxicity. Eur J Neurosci (2002) 0.82
Pattern electroretinography in a rat model of ocular hypertension: functional evidence for early detection of inner retinal damage. Exp Eye Res (2005) 0.81
Post-intoxication vaccination for protection of neurons against the toxicity of nerve agents. Toxicol Sci (2005) 0.80
Beneficial effect of orally administered myelin basic protein in EAE-susceptible Lewis rats in a model of acute CNS degeneration. J Autoimmun (2003) 0.80
Loss of autoimmune T cells correlates with brain diseases: possible implications for schizophrenia? Trends Mol Med (2006) 0.79
Chondroitin sulfate proteoglycan and its degradation products in CNS repair. Adv Pharmacol (2006) 0.78
The potential neuroprotective effects of weekly treatment with glatiramer acetate in diabetic patients after panretinal photocoagulation. Clin Ophthalmol (2011) 0.77
Neuroprotection induced by mucosal tolerance is epitope-dependent: conflicting effects in different strains. J Neuroimmunol (2006) 0.76
Chondroitin sulfate-derived disaccharide protects retinal cells from elevated intraocular pressure in aged and immunocompromised rats. Invest Ophthalmol Vis Sci (2007) 0.75
Differing views on spinal cord repair. Science (2002) 0.75
Developing a simple method to process bone samples prior to DNA isolation. Leg Med (Tokyo) (2008) 0.75
Immunomodulation by poly-YE reduces organophosphate-induced brain damage. Brain Behav Immun (2011) 0.75